COMMUNIQUÉS West-GlobeNewswire

Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer
18/10/2018
NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
Progressive Care Inc. Announces Beta Launch of New Proprietary Tele-PharmCo Software Platform for Real-Time Patient-to-Pharmacist Video Interactions
18/10/2018
MIAMI, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced the beta launch of its new proprietary tele-pharmacy software [...]
Evolus to Release Third Quarter 2018 Financial Results on Monday, November 5, 2018
18/10/2018
IRVINE, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced that it will release 2018 third quarter financial results after the close of U.S [...]
swyMed Joins AT&T's FirstNet Dealer Program
18/10/2018
Industry Experts in Public Safety Can Now Market, Promote and Co-Sell FirstNet Services LEXINGTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- swyMed, a provider of industry leading telemedicine and connectivity solutions [...]
Samumed to Present Preclinical Data on SM07883 at the 11th Clinical Trials on Alzheimer’s Disease (CTAD) Congress
18/10/2018
SAN DIEGO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it will present preclinical data on the company’s novel DYRK1A inhibitor, SM07883, a potential first-in-class drug for the treatment of [...]
Allena Pharmaceuticals Highlights Ongoing Efforts to Address Rare and Severe Metabolic Disorders Affecting the Kidney with Presentations at Upcoming Medical Meetings
18/10/2018
NEWTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]
Matinas BioPharma Announces Issuance of Key U.S. Patent for Prescription-Only Next Generation Omega-3 MAT9001 Providing Protection Through 2033
18/10/2018
BEDMINSTER, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, announced today that the U.S. Patent and Trademark Office (“USPTO”) [...]
Spectral Announces Presentation at the European Society of Intensive Care Medicine Oct 22nd and Publication of Overall Results of the EUPHRATES trial in JAMA
18/10/2018
TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) , a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]
Zosano Pharma to Host Key Opinion Leader Meeting on New Treatments for Migraine and the Migraine Patients’ Perspective
18/10/2018
Live webcast of the event available for analysts and investors FREMONT, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq: ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical [...]
Delcath Announces Enrollment of First Patient in ALIGN Trial
18/10/2018
The University of Tennessee Health Science Center, Methodist University Hospital, and West Cancer Center Begin Treatments in New Registration Trial for Intrahepatic Cholangiocarcinoma NEW YORK, Oct. 18, 2018 (GLOBE [...]
Parkview Health First to Activate New SMART® and FHIR® Technology Standards Through Healthwise
18/10/2018
New FHIR Technology to bring innovative patient education and Engagement capabilities through modern, interoperable technologies BOISE, Idaho, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Parkview Health announced today that it [...]
Opiant Pharmaceuticals Announces Receipt of National Institutes of Health Grant by Walter Reed Army Institute of Research and SUNY Upstate Medical University for Development of a Heroin Vaccine
18/10/2018
SANTA MONICA, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, [...]
Innovation Behind Precipio’s ICE-COLD PCR™ Platform Spotlighted in Media
18/10/2018
Articles Highlight Scientific and Economic Advantages Provided by Precipio’s Technology NEW HAVEN, Conn., Oct. 18, 2018 (GLOBE NEWSWIRE) -- The scientific and economic advantages of the proprietary, ultra-sensitive ICE- [...]
scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX®
18/10/2018
Type A Post-Action Meeting Minutes Received BURLINGTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that [...]
Biogen to Present Data from Alzheimer’s Disease Portfolio at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
18/10/2018
EMBARGOED FOR DISTRIBUTION Please note CTAD embargo policy: All materials submitted to CTAD are embargoed for publication and broadcast until the officially scheduled date and time of presentation, symposia or poster [...]
Translate Bio to Present Preclinical Data Supporting MRT5005 at the 32nd Annual North American Cystic Fibrosis Conference
18/10/2018
-- Findings support ongoing Phase 1/2 study of once-weekly nebulized MRT5005 in adults with cystic fibrosis -- LEXINGTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage [...]
MSI Methylation Sciences, Inc. (MSI) provides an update on its corporate activities, including its recent arbitration award of $20 million USD against Quark Venture Inc (Quark)
18/10/2018
BURNABY, B.C., Oct. 18, 2018 (GLOBE NEWSWIRE) -- In a January 2016 press release, MSI announced the results of its first Phase 2 clinical trial designed to evaluate the efficacy and safety of MSI-195 (Strada™) relative [...]
Bendcare Endorses Vectra® Testing for Patients with Rheumatoid Arthritis
18/10/2018
Vectra Provides Important Information to Help Rheumatologists Identify Patients at Increased Risk of Joint Damage SALT LAKE CITY, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader [...]
Iovance Biotherapeutics and MaSTherCell Announce New Manufacturing Services Agreement in Europe
18/10/2018
SAN CARLOS, Calif. and GOSSELIES, Belgium , Oct. 18, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor infiltrating [...]

Pages